With the exception of anaplastic large-cell lymphoma (ALCL) positive for anaplastic lymphoma-kinase (ALK), PTCL carries a poor prognosis with low OS and DFS with conventional chemotherapy. This evidence concerns the gene ALK and anaplastic large cell lymphoma.